Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease
This study is currently recruiting participants.
Verified October 2012 by Mount Sinai School of Medicine
Sponsor:
Douglas T. Dieterich
Collaborator:
Salix Pharmaceuticals
Information provided by (Responsible Party):
Douglas T. Dieterich, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT01654939
First received: July 30, 2012
Last updated: October 24, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2013 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |